Denali Therapeutics Inc.

DNLI· Nasdaq

Since Oct 5, 2025

Transactions: 7
Purchases: 0
Sales: 7
Purchase value: $0.00
Sale value: $1.30M

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Chin Peter ScottChief Medical Officer

Filed Sep 9, 2026Period of report Sep 4, 20260002124755-26-000007

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleSep 4, 2026	Common Stock^F1^F2^F3^F4	1,654	$22.29	$36.87K	204,538	Direct

Filing footnotes · 4

F1Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
F2The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $22.28 to $22.29 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3Includes 142,845 Unvested RSU's
F4Includes 1,790 shares acquired under the ESPP Purchase on June 1, 2026.

Open on SEC EDGAR

Thornberry NancyDirector

4Rule 10b5-1 plan disclosed

Filed Sep 4, 2026Period of report Sep 2, 20260001797826-26-000006

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Schuth Alexander O.COFO and Secretary

4Rule 10b5-1 plan disclosed

Filed Sep 3, 2026Period of report Sep 1, 20260001724311-26-000014

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
Sale

Schuth Alexander O.COFO and Secretary

Filed Aug 13, 2026Period of report Aug 11, 20260001724311-26-000013

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleAug 11, 2026	Common Stock^F1^F2^F3	2,857	$25.07	$71.62K

Schuth Alexander O.COFO and Secretary

Filed Jan 8, 2026Period of report Jan 6, 20260001724311-26-000005

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJan 6, 2026	Common Stock^F1^F2	17,218	$16.50	$284.10K	282,828

Watts Ryan J.Director · President and CEO

Filed Jan 8, 2026Period of report Jan 6, 20260001724310-26-000004

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJan 6, 2026	Common Stock^F1^F2	35,198	$16.50	$580.77K	296,833

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.